Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus

Abstract

Determining the levels of the erythrocyte-bound complement activation products, especially E-C4d, is an informative measure of SLE disease activity as compared with assessing serum C4 levels and should be considered for monitoring disease activity in patients with SLE.